Can, F. Et Al. 2019. Second autologous hematopoietic stem cell tranpslant versus chemoimmunotherapy in relapsed multiple myeloma after first transplantation: Single center data. 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , (Frankfurt, Germany), 502-503.

Can, F., Ocal, R., Kaynar, L., YEGİN, Z. A., Yagci, M., Haznedar, R., ... ÖZKURT, Z. N.(2019). Second autologous hematopoietic stem cell tranpslant versus chemoimmunotherapy in relapsed multiple myeloma after first transplantation: Single center data . 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) (pp.502-503). Frankfurt, Germany

Can, Ferda Et Al. "Second autologous hematopoietic stem cell tranpslant versus chemoimmunotherapy in relapsed multiple myeloma after first transplantation: Single center data," 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 2019

Can, Ferda Et Al. "Second autologous hematopoietic stem cell tranpslant versus chemoimmunotherapy in relapsed multiple myeloma after first transplantation: Single center data." 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , Frankfurt, Germany, pp.502-503, 2019

Can, F. Et Al. (2019) . "Second autologous hematopoietic stem cell tranpslant versus chemoimmunotherapy in relapsed multiple myeloma after first transplantation: Single center data." 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , Frankfurt, Germany, pp.502-503.

@conferencepaper{conferencepaper, author={Ferda Can Et Al. }, title={Second autologous hematopoietic stem cell tranpslant versus chemoimmunotherapy in relapsed multiple myeloma after first transplantation: Single center data}, congress name={45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)}, city={Frankfurt}, country={Germany}, year={2019}, pages={502-503} }